About Greg Verdine
Greg Verdine is an independent director at Stipple Bio.
Greg Verdine first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Greg Verdine in the role, so the role may have started earlier or lasted longer.
Stipple Bio, Inc.
Independent Director
2024 – 2026 · Cambridge, MA
Develops targeted cancer medicines for people with cancer.
Key Colleagues at Startups
The people Greg Verdine works with at each company, as listed on that company's latest Form D.
Stipple Bio, Inc. · Form D, Apr 6, 2026
Vineeta Agarwala
Director
TS
Thilo Schroeder
Managing Partner, Nextech and director
OH
Owen Hughes
Independent Director
AR
Aaron Ring
Associate Professor, Fred Hutch and director
DD
Derek DiRocco
Partner, RA Capital Management and director
Jeffrey Landau
Chief Executive Officer and director